We are live on ! Find out more
IMGO

Imago BioSciences, Inc. Common stock
IMGO

Delisted

IMGO was delisted on the 10th of January, 2023.

Back to rankings

52 hedge funds and large institutions have $607M invested in Imago BioSciences, Inc. Common stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,300% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 1

283% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 6

33% more funds holding

Funds holding: 39 → 52 (+13)

28% more capital invested

Capital invested by funds: $473M → $607M (+$134M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
52
Holders Change
+13
Holders Change %
+33.33%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
23
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.3M
2
WP
Woodline Partners
California
+$9.92M
3
Citadel Advisors
Citadel Advisors
Florida
+$9.51M
4
BlackRock
BlackRock
New York
+$4.92M
5
Millennium Management
Millennium Management
New York
+$3.52M

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$6.15M
2
FCM
Farallon Capital Management
California
-$4.63M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.77M
4
PA
Perceptive Advisors
New York
-$2.5M
5
DCM
Driehaus Capital Management
Illinois
-$412K
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$760K +$743K +32,058 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$664K +$85.6K +3,693 +15%
Swiss National Bank
28
Swiss National Bank
Switzerland
$612K +$598K +25,800 New
Charles Schwab
29
Charles Schwab
California
$598K +$32.8K +1,416 +6%
Ensign Peak Advisors
30
Ensign Peak Advisors
Utah
$593K +$579K +25,000 New
TD Asset Management
31
TD Asset Management
Ontario, Canada
$485K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$354K +$224K +9,667 +184%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$335K +$327K +14,137 New
Squarepoint
34
Squarepoint
New York
$268K +$262K +11,305 New
N
35
Nuveen
North Carolina
$242K – – –
VEA
36
Virtus ETF Advisers
New York
$215K +$210K +9,065 New
Morgan Stanley
37
Morgan Stanley
New York
$207K +$144K +6,218 +249%
JP Morgan Chase
38
JP Morgan Chase
New York
$161K +$70.2K +3,029 +81%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$154K +$150K +6,482 New
Bank of America
40
Bank of America
North Carolina
$145K +$123K +5,288 +619%
Deutsche Bank
41
Deutsche Bank
Germany
$140K +$7K +302 +5%
Wells Fargo
42
Wells Fargo
California
$139K +$134K +5,793 +10,163%
AIG
43
American International Group
New York
$123K -$3.57K -154 -3%
UBS Group
44
UBS Group
Switzerland
$108K +$84.3K +3,640 +392%
Allspring Global Investments
45
Allspring Global Investments
North Carolina
$94K +$91.9K +3,967 New
Citigroup
46
Citigroup
New York
$87K +$50K +2,159 +143%
Legal & General Group
47
Legal & General Group
United Kingdom
$75K +$52.3K +2,257 +248%
SO
48
STRS Ohio
Ohio
$52K – – –
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$46K +$19K +822 +76%
TRCT
50
Tower Research Capital (TRC)
New York
$28K +$17.3K +747 +173%
1
2
3

IMGO Hedge Fund Activity: Q4 2021 in Review

52 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q4 2021, worth a combined $607M — up 28% from $473M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IMGO positions and 1 closed out — a net gain of 13 holders — while 23 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $18.3M. The largest seller was Vanguard Group, cutting an estimated $6.15M.

  • 52 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q4 2021, up from 39 in Q3 2021.
  • Funds reported $607M of Imago BioSciences, Inc. Common stock stock for Q4 2021, up 28% quarter-over-quarter.
  • 14 funds opened new Imago BioSciences, Inc. Common stock positions in Q4 2021 and 1 closed out, a net change of +13 holders.
  • The largest Imago BioSciences, Inc. Common stock buyer in Q4 2021 was Fidelity Investments, an estimated $18.3M added.
  • The largest Imago BioSciences, Inc. Common stock seller in Q4 2021 was Vanguard Group, an estimated $6.15M sold.

Based on aggregated 13F filings for Q4 2021.